Tactile Systems Technology Inc

Tactile Systems Technology posted 2025 revenue of $329.5 million, up 12%, and ended the year with $83.4 million in cash. The company acquired Lymphotec and plans to integrate its fluid-monitoring technology to enhance patient surveillance and commercial workflows. Investments in a new CRM and expanded sales headcount are driving productivity gains, while updated Medicare coverage criteria have improved access to the FlexiTouch system. For 2026 the company issued guidance of 8%–11% revenue growth but warned a new Medicare prior authorization requirement for pneumatic compression devices could create a short-term headwind. » Mais em finance.yahoo.com

Tactile Systems Technology missed earnings expectations in the second quarter of 2025, reporting EPS of $0.14, while revenue came in above forecasts at $78.9 million. The respiratory product segment saw particularly strong growth, but the missed EPS and a decline in adjusted EBITDA led to a slight drop in the share price. The company remains optimistic for the full year and expects revenue growth of 6-8%. » Mais em de.investing.com